Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Los Angeles CA, Phoenix AZ, Tucson AZ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase 2, Phase 3, Recruiting
A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Los Angeles CA, Bishop CA
Sponsor: University of Southern California
Sex: All
Age: 0+
Code: NCT07332312
Recruiting
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Los Angeles CA, West Valley City UT, San Antonio TX,
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05985655
Phase 1, Phase 2, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Los Angeles CA, Cerritos CA, Newport Beach CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase 2, Phase 3, Recruiting
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
for
Breast Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 30 - 70+
Code: NCT07076147
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Los Angeles CA, Baldwin Park CA, Bellflower CA,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase 3, Recruiting
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
for
Healthy Subject, Hematologic and Lymphocytic Disorder,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 19+
Code: NCT03207854
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Los Angeles CA, Beverly Hills CA, Santa Monica CA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Los Angeles CA, Bakersfield CA, Surprise AZ, Peoria AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
for
NSCLC
Location: Los Angeles CA, Orange CA, Davis CA, Seattle WA,
Sponsor: Lung Cancer Mutation Consortium
Sex: All
Age: 0+
Code: NCT04712877
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Location: Los Angeles CA, San Antonio TX, Houston TX, St Louis MO,
Sponsor: Angiex, Inc.
Sex: All
Age: 18+
Code: NCT06440005
Phase 1, Recruiting
Confronting Cancer as a Community
for
Colorectal Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06063928
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for
Primary Immune Thrombocytopenia (ITP)
Location: Los Angeles CA, Oceanside CA, Phoenix AZ, Aurora CO,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06544499
Phase 3, Recruiting
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
for
Germ Cell Tumor
Location: Los Angeles CA, Downey CA, Long Beach CA, Loma Linda CA,
Sponsor: University of Sydney
Sex: All
Age: 11 - 50
Code: NCT02582697
Phase 3, Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Los Angeles CA, Duarte CA, Phoenix AZ,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Seattle WA, Houston TX, Madison WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase 1, Recruiting
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Los Angeles CA, Duarte CA, Denver CO, Houston TX,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05482893
Phase 1, Phase 2, Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Los Angeles CA, Houston TX, Grand Rapids MI, Toledo OH,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06095583
Phase 3, Recruiting
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
for
Breast Carcinoma
Location: Los Angeles CA, Newport Beach CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT06336928
Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations